Emergent BioSolutions IncNYSE:EBS
- LAST PRICE6.0250
- TODAY'S CHANGE (%)0.3250 (5.7018%)
- Bid / Lots6.0200/ 3
- Ask / Lots6.0300/ 3
- Open / Previous Close5.6400 / 5.7000
- Day Range
- 52 Week Range
- Volume658,382
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EBS |
|---|---|---|
| 09:32 ET | 60806 | 5.53 |
| 09:34 ET | 10182 | 5.5245 |
| 09:36 ET | 10051 | 5.69 |
| 09:38 ET | 54545 | 5.8399 |
| 09:39 ET | 46589 | 5.87 |
| 09:41 ET | 26794 | 5.905 |
| 09:43 ET | 26535 | 5.82 |
| 09:45 ET | 6349 | 5.795 |
| 09:48 ET | 23638 | 5.73 |
| 09:50 ET | 11088 | 5.83 |
| 09:52 ET | 7693 | 5.86 |
| 09:54 ET | 14797 | 5.83 |
| 09:56 ET | 21638 | 5.815 |
| 09:57 ET | 13786 | 5.785 |
| 09:59 ET | 2593 | 5.8 |
| 10:01 ET | 7533 | 5.855 |
| 10:03 ET | 19907 | 5.89 |
| 10:06 ET | 32149 | 5.9 |
| 10:08 ET | 57726 | 6.055 |
| 10:10 ET | 18468 | 6.06 |
| 10:12 ET | 23683 | 5.9605 |
| 10:14 ET | 16834 | 5.9799 |
| 10:15 ET | 10303 | 6.015 |
| 10:17 ET | 16589 | 6.035 |
| 10:19 ET | 17405 | 6 |
| 10:21 ET | 20066 | 6.04 |
| 10:24 ET | 15211 | 6.0417 |
| 10:26 ET | 8296 | 6.025 |
May 15, 2024
DJ Walgreens Launches Own Version of Overdose Reversal Drug Narcan, from 11:13AM ET on Wednesday May 15, 2024 by Dow Jones
11:13AM ET on Wednesday May 15, 2024 by Dow Jones
May 10, 2024
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024, from 7:17AM ET on Friday May 10, 2024 by Dow Jones
7:17AM ET on Friday May 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Emergent BioSolutions Inc | 298.7M | -0.6x | --- |
Pacira Biosciences Inc | 1.4B | 24.2x | --- |
SNDL Inc | 578.3M | -5.7x | --- |
Prestige Consumer Healthcare Inc | 3.2B | 15.4x | --- |
Collegium Pharmaceutical Inc | 1.1B | 15.8x | --- |
Tilray Brands Inc | 1.5B | -3.6x | --- |
Company Information
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Its portfolio of Bioservices consists of three but interrelated service pillars, such as development services (process and analytical development) and drug substance manufacturing.
Contact Information
- Headquarters
- 400 Professional Dr, Suite 400GAITHERSBURG, MD, United States 20879
- Phone
- 240-631-3200
- Fax
- 240-631-3203
Executives
- Independent Chairman of the Board
- Zsolt Harsanyi
- President, Chief Executive Officer, Director
- Joseph Papa
- Chief Financial Officer, Executive Vice President, Treasurer
- Richard Lindahl
- Executive Vice President - External Affairs, General Counsel, Corporate Secretary
- Jennifer Fox
- Executive Vice President - Quality and Ethics and Compliance
- Coleen Glessner
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $298.7M |
|---|---|
Revenue (TTM) | $1.2B |
Shares Outstanding | 52.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.64 |
EPS | $-10.87 |
Book Value | $12.44 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 0.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -39.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
